PIQRAY 200 MG + 50MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 28
Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil
-
Número de registro
1006811650061 -
GGREM
526520020095007 -
Código de barras
7896261021754
O que a fonte publica
- Detentor do registro
- NOVARTIS BIOCIENCIAS S.A
- Princípios ativos
- ALPELISIBE
- Embalagem
- 200 MG + 50MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 28
- Regime de dispensação
- Tarja Vermelha
- Tipo de produto
- Novo
- Classe terapêutica
- L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE
- Prescrição
- Sob prescrição ou restrito
Nomes pelos quais este registro é encontrado
Dados completos da fonte
{
"name": "PIQRAY 200 MG + 50MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 28",
"holder": "NOVARTIS BIOCIENCIAS S.A",
"stripe": "Tarja Vermelha",
"barcodes": [
"7896261021754"
],
"confaz87": false,
"currency": "BRL",
"marketed": null,
"ggremCode": "526520020095007",
"useDomain": "unknown",
"capApplies": null,
"icmsExempt": false,
"holderTaxId": "56.994.502/0001-30",
"priceRegime": "Regulado",
"productName": "PIQRAY",
"productType": "Novo",
"hospitalOnly": false,
"presentation": "200 MG + 50MG COM REV CT BL AL PLAS PVC/PCTFE TRANS X 28",
"sourceStatus": null,
"supplyRegime": "Tarja Vermelha",
"factoryPrices": {
"icms-0": "10204.34",
"icms-12": "11595.84",
"icms-17": "12294.38",
"icms-18": "12444.32",
"icms-19": "12597.95",
"icms-20": "12755.43",
"icms-21": "12916.89",
"icms-22": "13082.48",
"icms-23": "13252.39",
"icms-17.5": "12368.89",
"icms-19.5": "12676.20",
"icms-20.5": "12835.65",
"icms-22.5": "13166.89",
"icms-12-alc": "10353.44",
"icms-17-alc": "10977.12",
"icms-18-alc": "11111.00",
"icms-19-alc": "11248.16",
"icms-20-alc": "11388.77",
"icms-21-alc": "11532.93",
"icms-22-alc": "11680.79",
"icms-23-alc": "11832.48",
"withoutTaxes": "9111.02",
"icms-17.5-alc": "11043.66",
"icms-19.5-alc": "11318.03",
"icms-20.5-alc": "11460.39",
"icms-22.5-alc": "11756.14"
},
"pisCofinsList": "Negativa",
"substanceText": "ALPELISIBE",
"targetSpecies": [],
"consumerPrices": {
"icms-0": "13688.76",
"icms-12": "15555.41",
"icms-17": "16492.47",
"icms-18": "16693.61",
"icms-19": "16899.70",
"icms-20": "17110.96",
"icms-21": "17327.55",
"icms-22": "17549.68",
"icms-23": "17777.61",
"icms-17.5": "16592.43",
"icms-19.5": "17004.67",
"icms-20.5": "17218.57",
"icms-22.5": "17662.91",
"icms-12-alc": "14313.02",
"icms-17-alc": "15175.22",
"icms-18-alc": "15360.31",
"icms-19-alc": "15549.92",
"icms-20-alc": "15744.31",
"icms-21-alc": "15943.60",
"icms-22-alc": "16148.01",
"icms-23-alc": "16357.71",
"withoutTaxes": "12595.45",
"icms-17.5-alc": "15267.21",
"icms-19.5-alc": "15646.51",
"icms-20.5-alc": "15843.32",
"icms-22.5-alc": "16252.17"
},
"invalidBarcodes": [],
"activeSubstances": [
"ALPELISIBE"
],
"therapeuticClass": "L1H9 - OUTROS ANTINEOPLÁSICOS INIBIDORES DA PROTEÍNA KINASE",
"commercialisation": {
"year": 2025,
"marketed": true
},
"priceAnalysisNote": null,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "br.anvisa.cmed-prices"
},
"patientEligibility": "not-assessed",
"registrationNumber": "1006811650061",
"targetSpeciesStatus": "not-reported",
"administrativeStatus": "unknown",
"prescriptionCategory": "prescription-or-restricted",
"prescriptionRequired": true,
"therapeuticClassCode": "L1H9",
"commercialDestination": null,
"registrationNumberFlag": null
}
Leia este registro a partir do seu próprio software
O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=br" \
--data-urlencode "sourceId=br.anvisa.cmed-prices" \
--data-urlencode "id=br:cmed:presentations:526520020095007"